[go: up one dir, main page]

MXPA00007774A - Tobacco products with vitamin e - Google Patents

Tobacco products with vitamin e

Info

Publication number
MXPA00007774A
MXPA00007774A MXPA/A/2000/007774A MXPA00007774A MXPA00007774A MX PA00007774 A MXPA00007774 A MX PA00007774A MX PA00007774 A MXPA00007774 A MX PA00007774A MX PA00007774 A MXPA00007774 A MX PA00007774A
Authority
MX
Mexico
Prior art keywords
tobacco
additive
alpha
cigarette
tocopherols
Prior art date
Application number
MXPA/A/2000/007774A
Other languages
Spanish (es)
Inventor
Joseph D Russo
Original Assignee
Rousseau Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rousseau Research Inc filed Critical Rousseau Research Inc
Publication of MXPA00007774A publication Critical patent/MXPA00007774A/en

Links

Abstract

A substantially pure Vitamin E type compound is added to tobacco and non-tobacco for a smokeable or smokeless product to achieve less irritation and antioxidant benefits. In a preferred embodiment, a substantially pure"dry"powdered ester analog of Vitamin E, such as Vitamin E acid succinate or spray dried Vitamin E acetate, is mixed directly with the tobacco or non-tobacco product during the manufacturing process. These Vitamin E analogs can also be inserted into a cigarette filter (20), holder and/or paper (26), either in powdered form or in microencapsulated form. Although not preferred, a common oily form of Vitamin E can be used in the present invention so long as it does not ruin the appearance and function of the smokeable or smokeless product.

Description

TOBACCO PRODUCTS WITH VITAMIN E This is a partial continuation of the patent application of E.U.A :, Serial No. 09 / 020,958, entitled "Cigarettes With Vitamin E", filed on February 9, 1998, still pending.
TECHNICAL FIELD OF THE INVENTION The present invention relates to tobacco products for smoking, such as cigarettes, cigars (cigars), pipe tobacco (loose) and smokeless tobacco products, also known as chewing tobacco. More particularly, a novel form of cigarettes, cigars and loose tobacco, which can be smoked, and chewing tobacco are disclosed, which include an additive of type Vitamin E, which improves health.
BACKGROUND OF THE INVENTION Health problems associated with cigarette smoking, cigarette smoking, pipe smoking and chewing tobacco have been made public. In several scientific studies, smoking cigarettes, cigars, pipe and the use of chewing tobacco have been linked to diseases of the lung, throat, mouth and "• other cancers as well as emphysema, smoker's cough and heart problems. Several attempts have been made to govern the health problems through the reformulation of the 5 cigarettes. For example, special cigarette mixes have been formulated for cigarettes, with reduced levels of tar and nicotine. Unfortunately, each reduction in the level of tar and nicotine has been accompanied by a corresponding reduced level of satisfaction of the smoker. Thus, sales of reduced tar and nicotine cigarettes, particularly those commercially classified as "ultra-low tar and nicotine", do not meet expectations. More recently, efforts have been made to remove complete the additives of cigarettes. While such "additive-free" cigarettes can provide purer smoke, it is not clear whether they also provide any corresponding health benefits. In fact, because they do not contain additive diluents, their tar and nicotine levels are increased. Attempts have been made to make insert additives in cigarettes, to displace some of the f dangerous substances present in tobacco. For example, U.S. Patent No. 5,016,655 ("'655" patent) recommends the insertion of alcohols in tobacco or cigarette filters in order to neutralize the carcinogenic effect of N-nitrosoamines, such such as N1-nitrosonoronicotine (NNN). According to the '655 patent, these alcohols can advantageously be packaged with other chemicals, such as vitamins A, B, C and E. However, in Table IV of the' 655 patent, it is taught that the use of Vitamin E as a unique additive (ie, apart from a mixture of alcohol) is not effective in neutralizing the NNN. Similarly, in the published PCT application, No. WO 95/28098, it is suggested that cigarette additives can be formed from a complex of eukaryotic cell cultures with Vitamin E or a solution of natural substances of vegetable origin, which have anti-mutagenic and aromatic properties, also with Vitamin E. However, there is no suggestion in this publication of the PCT that Vitamin E may have some efficacy as a unique additive for cigarettes.
^ In U.S. Patent No. 3,339,558 / "patent '558") and 3,667,478 ("patent' 478"), Vitamin A is recommended as a primary additive for cigarettes to promote better health. The '558 patent teaches that Vitamin A must be inserted into the filter medium of the cigarette into ruptured capsules, while the '478 patent teaches that a stabilized aqueous emulsion of active Vitamin A must be applied to the cigarette tobacco. The '478 patent indicates that other vitamins, such such as Vitamins C, D, E, etc., can be added to the Vitamin A emulsion, but it does not suggest that any of the other vitamins can be used advantageously as a single additive. As noted, none of these patents of the previous technique suggests the use of Vitamin E or an analogue of Vitamin E as a unique additive of cigarettes, much less what mechanisms of form, quantities and delivery should be used for such a unique additive of the type of Vitamin E.
SUMMARY OF THE INVENTION The present invention provides an effective technique for adding a substantially pure Vitamin E-type compound to cigarettes, cigars, loose pipe tobacco, and smokeless or "chewing" tobacco, as this tobacco is commonly known. smoke. In smoking tobacco products, such substantially pure Vitamin E additives have been found, unexpectedly, to achieve a greater degree, a much less irritating smoke, along with the antioxidant benefits of Vitamin E. This beneficial effect can also be applied to indirect irritation of smoke, commonly experienced by non-smokers. In chewing tobacco, the additives of Vitamin E, substantially pure, have been found, unexpectedly, reduce irritation, to the cheeks, gums, palate and esophagus. In a preferred embodiment, a "dry", substantially pure powder analogue of Vitamin E, known as d-alpha-tocopheryl acid succinate or Vitamin E acid succinate, is directly mixed with tobacco used in smoking tobacco and chewing tobacco, during the manufacturing process. This analog of Vitamin E can also be inserted into a cigarette filter, holder or paper or wrapper. Other "dry" forms of the Vitamin E analogues, which can be advantageously used with the present invention, are d-alpha-tocopheryl acetate, d-alpha-tocopherol, dl-alf -tocopherol or natural mixed tocopherols forms, which are spray-dried on a suitable carrier (for example, gelatin or acacia gum). Although not preferred, a common clear, oily viscous form of natural Vitamin E (d-alpha-tocopherol) or its liquid analogs may be used in the present invention as long as it is used in a manner that does not spoil the appearance and function of the product that can be smoked (for example, incorporated through the microencapsulation or diffused inside the tobacco or filter, in such a way that it is stabilized and does not leach on the paper or wrappers of the cigarettes, to show an oily residue) or agglomerate in chewing tobacco. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 shows a side elevational view of a typical cigarette. Figure 2 shows a side elevational, cropped view of the typical cigarette of Figure 1. Figure 3 shows a side elevation view, cut away, of an alternative form of cigarette, which can accommodate a filter insert.
Figure 4 is a side elevational view, cut away, of a second alternative form of cigarette, which can accommodate a filter insert.
DESCRIPTION OF THE SPECIFIC MODALITIES Vitamin E or d-alpha-tocopherol, and its analogs, has been found to act as an anti-inflammatory and an anti-oxidant, which can deactivate free radicals that damage cells. Vitamin E is most commonly obtained in a viscous, oily form, from vegetable oil distillates. Vitamin E is then used in this oily form to apply directly to the skin tissue or taken orally in an encapsulated vitamin supplement, daily. While the common oily form of Vitamin E may be acceptable for many uses, it presents problems when applied to the modified smoking or chewing tobacco of the present invention. For example, if the oily Vitamin E directly applied to a cigarette is applied directly, it will have a tendency to migrate and exude on the cigarette paper and thus ruin the feel and appearance of the cigarette. Likewise, the common oily form of Vitamin E will tend to interact with tobacco and other natural ingredients, in a way that detrimentally affects the stability of this Vitamin E. It is for these reasons that the "dry" analogs of Vitamin E they are preferred for the present invention, in order to better maintain a clean feel and appearance for smoking and chewing tobacco, as well as preserving the stability of this Vitamin E. A "dry" ester, analogous to Vitamin E, which is preferred for This invention is variably known as d-alpha-tocopheryl acid succinate, Vitamin E acid succinate, 2R acid succinate, 4'R, 8'R-alpha-tocopheryl, d-alpha-tocopheryl hydrogen succinate and Succinate acid 2, 5, 7, 8-tetramethyl-2- (4 ', 8', 12 '-trimethyltridecyl) -6-chromanol. The acid succinate of Vitamin E has the empirical formula of C33H5405, and a molecular weight of 530.79. The chemical structure of the acid succinate of Vitamin E is as follows: The acid succinate of Vitamin E is a derivative of d-alpha-tocopheryl succinate, in the form of a white to almost white crystalline powder, with little or no odor or taste. The acid succinate of Vitamin E can be prepared by vacuum distillation and succinylation of edible vegetable oil products. This acidic succinate of Vitamin E can be obtained commercially from Eastman Chemical Corporation, of Kingsport, Tennessee, as the Eastman product PM4009 or E-1210. The acidic succinate of Vitamin E can also be obtained commercially from Henkel Corporation, of LaGrange, Illinois, as COVITOL® 1210 or from Archer Daniels Midland Company, of Decatur, Illinois. Another "dry" ester analog of Vitamin E, which is preferred for the present invention, is a spray-based carrier form of Vitamin E, variably known as di-alpha-tocopheryl acetate, Vitamin E, 2R, 4'R, 8'R-alpha-tocopheryl acetate and 2, 5, 7, 8-tetramethyl-2- (4 ', 8', 12'-trimethyltridecyl) -6-chromanol acetate. This alternative "dry" form of Vitamin E is also typically derived from vegetable oils and then spray dried on gelatin or acacia gum. The acetate of Vitamin E has the empirical formula of C31H5203 and a molecular weight of 472.75. The chemical structure of Vitamin E acetate is as follows: The preferred "dry" form of Vitamin E acetate is an acetate derivative of d-alpha-tocopheryl, in the form of a fine powder that can be dispersed in water, containing the d-alpha-tocopheryl acetate dried by sprayed on a treated carrier on the surface. It is light golden in color, with a mild smell and flavor. The Vitamin E acetate, spray dried on a gelatin carrier, can be obtained commercially from Archer Daniels Midland Corporation, as the product E-700. It can also be obtained commercially from Henkel Corporation, of LaGrange, Illinois, as COVITOL® 700 WD, a form of Vitamin E acetate, which is spray-dried on an acacia gum carrier. Other "dry" forms of Vitamin E, which are suitable for the present invention and obtainable from Henkel Corporation, include COVITOL® F-350M and COV-OX® T-30P. COVITOL® F-350 is a cream-colored powder containing mixed natural tocopherols (ie, including the α-, β-, β-, and β- forms of tocopherol), spray dried on a gelatin carrier, dextrin and glucose, which is superficially treated. The taste and odor of COVITOL® F-350M is mild to moderate. The COV-OX® T-30P is a light colored powder, which also contains "natural mixed tocopherols" (ie, which includes the a-, ß-,? - and d-forms of tocopherol), spray-dried on an acacia gum carrier Similarly, in COVITOL® F-350M, the taste and odor of COV-OX® T-30Pes is mild to moderate. As another "dry" alternative, a synthetic form of Vitamin E, ie, dl-alpha-tocopherol, which is spray-dried on a suitable carrier (eg, gelatin or acacia gum) can be advantageously used in the present invention. The preferred "dry" forms of Vitamin E can be incorporated into smoking or chewing tobacco, in a number of different ways, including direct mixing with tobacco or inserted into the cigarette filter, holder or paper, or into its powder form, spray dried form or microencapsulated form. These methods of incorporation can be better explained in relation to the drawings. Referring now to Figure 1, a typical form of cigarette 10 is shown, which includes a filter section 12 and a tobacco section 14. A cropped view of this typical cigarette is shown in Figure 2, where the tobacco rod 18, the filter 20, the tobacco paper 22, the cap wrapper 24 and the filter paper 26 can be seen clearly. In an embodiment of the present invention, a "dry" form, substantially pure, of Vitamin E, can be mixed in, sprinkled or sprinkled on the whole or cut tobacco leaves, during the manufacturing process. In that way, the "dry" form, substantially pure, of Vitamin E, will already be incorporated in the tobacco, when wound up in a cigarette, shown in Figures 1 and 2, or packed in a container of chewing tobacco. While the amount of Vitamin E to be used in this process may vary, it is expected that between 0.1 and 5000 milligrams of the analog of Vitamin E or Vitamin E is the appropriate amount of the product to smoke or the portion of tobacco to be used. chew, which contains 400 to 1200 milligrams of tobacco, with a more preferred amount of Vitamin E or the analog of Vitamin E being between 0.1 and 20.0% by weight of tobacco or 0.4 to 240 milligrams for a product that you will smoke or the portion of chewing tobacco that contains 400 to 1200 milligrams of tobacco. In a second embodiment, the "dry" form of Vitamin E can be incorporated in the filter 20 of the cigarette, or as dispersed powder particles 30, molten liquid within the medium the microencapsulated filter or particles 30A of powder. Such powdered particles 30 or microencapsulated powder particles 30A can also be incorporated into the paper 22 of the tobacco, plug wrap 24 and / or filter paper 26. Referring now to Figure 3, an opening 32 is shown in the middle of the filter 20, which can accommodate the concentrated Vitamin E or the analogue of Vitamin E, in any powdered form or encapsulated form. Alternatively, as shown in Figure 4, an insert 36 of Vitamin E or the analogue of Vitamin E, can be obtained in the filter section, between the actual filter 20 and the tobacco section 14. This insert 36 may contain an encapsulated section 14. This insert 36 may contain an encapsulated compound of Vitamin E or a compound of Vitamin E powder, properly wrapped (for example, wrapped in paper). Similarly, a narrower Vitamin E insert (not shown) can be incorporated in the cigarette section 14 of the cigarette. The microencapsulation can be used in the present invention as a suitable delivery device for a Vitamin E compound in its preferred "dry" form or the most common oily form. Initially, the microencapsule isolates the Vitamin E compound and provides its controlled release so that, for a tobacco product that can be smoked, it can interact with its smoke current environment. The microencapsulation construction of the cover wall must be sufficiently compatible with the Vitamin E compound contained therein, to retain this Vitamin E compound until such time, since the heat of the smoke causes the cover to open. In other words, the microcapsule is stable inside the cigarette until it is added. At that point, the heat of the smoke initiates the release of the Vitamin E compound. Ideally, the cover wall should comprise between 20 and 50% of the capsule's volume for stability, and thus resist rupture in manufacture, packaging and handling of the cigarette consumer. The microcapsules should be 3 to 10 microns in circumference, when they are placed on the paper 22, 24, 26 of the cigarette or mixed with the tobacco 18 in order to avoid undesired inequalities in the cigarette paper or remain invisible if placed in the cigarette paper. tobacco Greater circumferences of up to 50 microns are acceptable if the microcapsules are placed in the cigarette filter. Also, the capsules can be dyed with suitable food dyes to match the color of the filter or tobacco. This microencapsulation of Vitamin E can be accomplished by a roof wall construction, referred to as the C-CAP Process of Insulation Technologies Corporation, of Darby, Pennsylvania. The general specification of the M-CAP cover walls are capsules as small as three microns, with melting temperatures of 18 to 343 ° C. The encapsulation material of the cover wall can be ELVAX ™ (ethylene / copolymers). vinyl acetate) or similar cellulite material, having the desired characteristics of a suitable cover wall release temperature of 18 to 343 ° C. ELVAX ™ is an ethylene vinyl acetate resin, as described in "Material Data Sheet - VAX001," dated October 20, 1986, from E.l. DuPont de Nemours & CO., Of Wilmington, Delaware. Other cover wall candidates include BERMOCOLL ™, which is an ethylhydroxyethylcellulose, manufactured by Berol Kemi AB, of Satenungsund, Sweden; K &K Gelatin, which is a gelatin manufactured by the Kind & Knox by Knox Gelatine, Inc., by Saddler Brook, N.J .; N-LOK ™, which is an emulsion stabilizer material from National Starch and Chemical Corporation, of Bridgewater, N.J .; and CAPSUL ™, a modified starch material, which is described in "Product Data: Bulletin No. 409" by Natinal Starch and Chemical Corporation, of Bridgewater, N.J. In the case of the chewing tobacco product, the saliva solubility of the powder form of Vitamin E releases the active ingredients. In the case of the oily form of Vitamin E, or less soluble forms of Vitamin E, saliva will leach Vitamin E along with other components of the chewing tobacco product.
Apart from the microencapsulation, the use of the common oily form of Vitamin E is only recommended for the present invention when it is introduced, so as not to get soaked through the papers of the cigarettes, 22, 24, 26 or agglomerate the tobacco to chew . Et can be best achieved by applying the oily form of Vitamin E to the tobacco leaves, briefly after harvest. As the tobacco leaves are then taken through their various stages of drying, the oily form of Vitamin E will tend to soak in tobacco leaves and thus migration is less likely. This process can be helped through the addition of other suitable carriers or chemicals that dry the oil. As previously noted, it is thought that the viscous, oily, common form of Vitamin E has the tendency to interact with tobacco and other natural ingredients and thus may detrimentally affect the stability of Vitamin E.
EXAMPLE 1 A comparison was made between a cigarette without a normal filter and a cigarette without a modified filter to include the "dry" form, substantially pure, of the Vitamin E analog. For this comparison, 7.5 grams of CHESTERFIELD® tobacco was removed from a CHESTERFIELD® cigarette and were mixed with 0.1 gram of Vitamin E acid succinate. The mixed tobacco mixture was formed into an unfiltered cigarette, using a Rizla self-winding box. A control cigarette, without Vitamin E analogue additive, was also formed using the same Rizla self-winding box. When smoked, the control cigarette was found to cause throat and lung irritation for both smokers and non-smokers. In contrast, the cigarette with the acid succinate of Vitamin E had the same taste when smoking, but was found not to cause irritation in the throat or lungs, both smokers and non-smokers.
EXAMPLE 2 A second compassion was made between a cigarette with a normal filter, a filter cigarette with oily Vitamin E injected into the filter and Vitamin E injected into the length of the tobacco. In this second comparison, the control cigarette was a normal MARLBORO® cigarette. In two separate MARLBORO® cigarettes, Vitamin E was taken from a Vitamin E capsule with a syringe and injected into the filter of one cigarette, and into the length of the other cigarette's tobacco. The three cigarettes were lit with a butane gas lighter and three equal alternative puffs of each cigarette were made by a non-smoker. The control cigarette was found to irritate the non-smoker's lungs and induce coughing. The cigarette with Vitamin E in the filter was found to be less irritating, but still induced a non-aggravating reaction in the lung and a mild cough. The cigarette with Vitamin E along the length of the tobacco did not produce irritation. Also, the taste of the tobacco cigarette with Vitamin E gave the impression that it had been improved.
EXAMPLE 3 A third comparison was made between a normal portion of chewing tobacco and a portion of modified chewing tobacco to include a "dry" form, substantially pure, of the Vitamin E analog. For this comparison, 1.0 gram of tobacco for chewing, long cut, SOCAL® unmodified, was placed first in the mouth of a person who does not chew tobacco, between the cheeks and the gum. This unmodified chewing tobacco produced a pleasant taste, but also a simultaneous burning sensation in the mouth, throat and esophagus, which, together with an induced cough, forced the person to spit out unmodified chewing tobacco. To remove the burning sensation from his mouth, the person washed his mouth with water. However, the burning sensation in the mouth and throat persisted for 5 minutes after the initial wash. Approximately four hours later, enough to ensure that the sensitivity of the burning sensation had completely disappeared, the person who does not habitually chew tobacco then mixed 0.1 gram of the acid succinate of Vitamin E, obtained from Eastman Chemical Corporation, Kingsport, Tennessee with 10.0 chews of chewing tobacco, long cut, SOCAL®. A portion of 1.0 gram of this chewing tobacco, modified with Vitamin E, was then placed in the mouth of the person not used to chewing tobacco, between the cheeks and the gum. Like unmodified chewing tobacco, this modified tobacco with Vitamin E produced a similar pleasant taste. However, unlike unmodified chewing tobacco, this chewing tobacco modified with Vitamin E did not irritate in any way.
In the above specification, the invention has been described with reference to specific preferred modalities and methods. However, it will be apparent to those skilled in the art, that various modifications and changes can be made, without departing from the broader spirit and scope of the invention., as indicated in the appended claims. For example, the Vitamin E compounds of the present invention can be used not only in cigarettes, but also in other tobacco products, such as cigars or pipe tobacco, as well as in tobacco-free smoking products (eg, cigarettes). of Cannabis Indica). As in cigarette applications, which have been previously discussed, Vitamin E compounds can be advantageously mixed with cigar tobacco, pipe tobacco, chewing tobacco or non-smoking tobacco products and chewing products without tobacco, during the process of manufacturing. Alternatively, in the case of pipe tobacco, it can be mixed with the tobacco by the consumer, before the tobacco mixture is loaded into a pipe. In the same way, the consumer can add it to the chewing tobacco. For these reasons, the specification and drawings are, therefore, considered as illustrative, rather than in a restrictive sense; the invention is limited only by the appended claims.

Claims (38)

1. A tobacco product, which incorporates between 0.1 and 20.0% by weight of an additive, substantially pure, of the group consisting of tocopherols, their analogues and their derivatives.
2. The tobacco product of claim 1, wherein the additive is selected from the group consisting of the alpha-tocopherols, their analogs and their derivatives.
3. The tobacco product of claim 1, wherein the additive is selected from the group consisting of d-alpha-tocopherol, the acid succinate of d-alpha-tocopheryl, d-alpha-tocopheryl acetate, mixed tocopherols and the dl -alpha-tocopherol.
4. The tobacco product of claim 1, wherein the additive is the acid succinate of d-alpha-tocopheryl.
5. The tobacco product of claim 1, wherein this tobacco product is for chewing.
6. A tobacco product, which incorporates a substantially pure additive, from the group consisting of the dry powder forms of tocopherol, its analogues or its derivatives.
7. The tobacco product of claim 6, in the additive is selected from the group consisting of the acid succinate of d-alpha-tocopheryl, d-alpha-tocopheryl acetate, spray-dried on a suitable carrier, mixed tocopherols, spray-dried on a suitable carrier, and dl-alpha tocopherol, spray-dried on a suitable carrier.
8. The tobacco product of claim 7, wherein the tobacco product is a chewing tobacco.
9. A chewing tobacco product, which incorporates between 0.1 and 20.0% by weight of a non-complex additive, whose only anti-oxidant is selected from the group consisting of dry, powder tocopherols, their analogues and their derivatives.
10. A chewing tobacco product, which incorporates between 0.1 and 20% by weight of an additive, selected from the group of dry powder tocopherols, their analogs and their derivatives, which are substantially free of low molecular weight alcohols, other vitamins, cultures of eukaryotic cells reacted or that form complexes with natural substances of vegetable origin, which have anti-mutagenic and flavoring properties.
11. A method for obtaining a healthier chewing tobacco product, comprising the steps of mixing an additive, substantially pure, of the group consisting of tocopherols, their analogs and their derivatives, with tobacco.
12. The method of claim 11, wherein the additive is a dry powder form of tocopherols, their analogs and their derivatives.
13. The method of claim 12, wherein the dry powder form of the additive is selected from the group consisting of the acid succinate of d-alpha-tocopheryl, d-alpha-tocopheryl acetate, spray-dried on a suitable carrier, mixed tocopherols , spray-dried on a suitable carrier and 1-alpha-tocopherols, spray-dried on a suitable carrier.
14. The method of claim 13, wherein the additive is the d-alpha-tocopheryl acid succinate.
15. A non-tobacco product, which can be smoked or chewed, which incorporates between 0.1 and 20.0% by weight of a substantially pure additive from the group consisting of tocopherols, their analogues and their derivatives.
16. The non-tobacco product, which can be smoked or chewed, according to claim 15, in which this product is Indica Cannabis.
17. A tobacco cigarette, which incorporates between 0.1 and 5000 milligrams of a substantially pure additive from the group consisting of tocopherols, their analogs and their derivatives.
18. The tobacco cigarette of claim 17, wherein the additive is selected from the group consisting of the alpha-tocopherols, their analogs and their derivatives.
19. The tobacco cigarette of the claim 17, in which the additive is selected from the group consisting of d-alpha-tocopherol, d-alpha-tocopheryl acid succinate, d-alpha-tocopheryl acetate, mixed tocopherols and dl-alpha-tocopherol.
20. The tobacco cigarette of claim 17, wherein the additive is the d-alpha-tocopheryl acid succinate.
21. The tobacco cigarette of claim 17, wherein the additive is microencapsulated.
22. A tobacco cigarette, incorporating an additive, substantially pure, from the group consisting of the dry powder forms of tocopherol, its analogues or its derivatives.
23. The tobacco cigarette of the claim 22, in which the additive is selected from the group consisting of the d-alpha-tocopheryl acid succinate, d-alpha-tocopheryl acetate, spray-dried on a suitable carrier, mixed tocopherols, spray-dried on a suitable carrier and the dl-alpha-tocopherol, spray-dried on a suitable carrier.
24. The tobacco cigarette of the claim 23, in which the appropriate carrier is acacia gum.
25. The tobacco cigarette of claim 23, wherein the suitable carrier is gelatin.
26. The tobacco cigarette of claim 22, wherein the additive is the acid succinate of d-alpha-tocopheryl.
27. The tobacco cigarette of claim 22, wherein the additive is mixed with the tobacco of the cigarette.
28. The tobacco cigarette of claim 22, wherein the additive is incorporated in the cigarette filter.
29. A tobacco cigarette in which an additive. Substantially pure, of the d-alpha-tocopheryl acid succinate is mixed with the tobacco of the cigarette.
30. A tobacco cigarette, which incorporates between 0.1 and 5000 milligrams of a non-complex additive, whose only anti-oxidant is selected from the group consisting of dry powder tocopherols, their analogues and their derivatives.
31. A tobacco cigarette, which incorporates between 0.1 and 5000 milligrams of an additive, selected from the group of dry powder tocopherols. its analogs and its derivatives, which is substantially free of alcohols, other vitamins, cultures of eukaryotic cells and natural substances of vegetable origin, which have anti-mutagenic and flavoring properties.
32. A method for obtaining a healthier cigarette, comprising the steps of: mixing an additive, substantially pure, of the group consisting of the tocopherols, their analogues and their derivatives, with the tobacco of the cigarette; Roll the mixture in a cigarette, with the use of cigarette wrapping paper.
33. The method of claim 32, wherein the additive is in a dry powder form.
34. The method of claim 33, wherein the dry powder form of the additive is selected from the group consisting of the acid succinate of d-alpha-tocopheryl, d-alpha-tocopheryl acetate, spray-dried on a suitable carrier, mixed tocopherols , spray-dried on a suitable carrier and dl-alpha-tocopherols, spray-dried on a suitable carrier.
35. The method of claim 32, wherein the additive is the acid succinate of d-alpha-tocopheryl.
36. The method of claim 32, wherein the additive is a microencapsulated oily form of -alpha-tocopherol.
37. A cigarette constructed using the method of claim 32.
38. A smoking product that incorporates between 0.1 and 5000 milligrams of a substantially pure additive from the group consisting of tocopherols, their analogues and their derivatives.
MXPA/A/2000/007774A 1998-02-09 2000-08-09 Tobacco products with vitamin e MXPA00007774A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09020958 1998-02-09
US09064021 1998-04-21

Publications (1)

Publication Number Publication Date
MXPA00007774A true MXPA00007774A (en) 2002-07-25

Family

ID=

Similar Documents

Publication Publication Date Title
AU752456B2 (en) Tobacco products with Vitamin E
US6079418A (en) Tobacco products with dry powdered vitamin E
US12201143B2 (en) Flavor delivery article
US4715390A (en) Matrix entrapment of flavorings for smoking articles
WO2003009711A1 (en) Taste changeable tobacco
US20230345995A1 (en) Delivery systems
US4620554A (en) Moderating agent of cigarette taste
KR960015947B1 (en) Citrus-flavored tobacco articles
KR102519563B1 (en) precision pod
KR102640562B1 (en) Smoking article with reduced tobacco odor and manufacturing method thereof
MXPA00007774A (en) Tobacco products with vitamin e
US20080017205A1 (en) Method and Device for Releasing Flavor and Odor Substances
JP3068084B1 (en) Tobacco substitute composition
Dunn Jr JOHN SLADE